Recently, an alternative approach was followed [64] in which the glycosyltransferases ST3GAL2, ST3GAL3, B4GALT5, and B3GALT4 were suggested as a further predictor in identifying GD2-positive phenotypes in cancer patients. This evidence concerns the gene B4GALT5 and cancer.